Focus:
Industry News
-
18 September 2019
US FDA partners Australia and Canada for cancer therapies review
The US Food and Drug Administration (FDA) has partnered with the Australian Therapeutic Goods Administration (TGA) and Health Canada to expedite the approval of oncology therapies.
-
18 September 2019
Study shows use of arthritis drug in blood cancer treatment
A study led by the University of Sheffield, UK, has demonstrated that a low-cost rheumatoid arthritis drug, methotrexate (MTX), can help to treat patients with blood cancer.
-
16 September 2019
FDA to review ranitidine after detecting cancer-causing contamination
The US Food and Drug Administration (FDA) has issued a statement regarding the safety of the drug ranitidine after the detection of N-nitrosodimethylamine (NDMA) in some samples.
-
13 September 2019
Penn researchers study cancer therapy in heart disease treatment
A research team from Penn Medicine at the University of Pennsylvania has been studying CAR T-cell therapy, which is used to fight cancer, in the treatment of heart disease.
-
12 September 2019
UK Government confirms disruption to medicines in event of no-deal Brexit
A document published by the UK Government laying out the worst case scenario if the UK leaves the European Union (EU) with no deal on 31st October stated there will...
-
12 September 2019
UK initiates £200m genome project to address fatal diseases
The UK Government has launched a £200m whole-genome sequencing project in alliance with pharmaceutical companies and health experts to tackle life-threatening diseases.
-
6 September 2019
EC expands label of Janssen’s Stelara to include ulcerative colitis
Johnson & Johnson subsidiary Janssen has announced the European Commission (EC) has approved Stelara (ustekinumab) for patients with moderately to severely active ulcerative colitis (UC).
-
5 September 2019
AZ licenses PARPi to Theragnostics to develop novel radiopharmaceuticals
UK-based clinical stage biotech Theragnostics has signed a licensing agreement with AstraZeneca (AZ) related to global rights to selected Poly ADP-Ribose Polymerase inhibitors (PARPis), and aims to transform them into...
-
2 September 2019
Gavi Vaccine Alliance seeks $7. 4bn to immunise 300 million people
Gavi, the Vaccine Alliance has initiated a $7.4bn fundraising drive to support the immunisation of 300 million children against 18 diseases, which could save up to eight million lives from...
-
2 September 2019
Researchers find new drug with promise for malaria treatment
An international research team led by the University of Glasgow has discovered a new drug that could kill the malaria-causing parasite, offering hope for the treatment of the disease.